SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and intense social media debate, driven by institutional accumulation, uncertainty surrounding geopolitical tensions, and skepticism regarding recent market movements. The community remains deeply divided, with bulls pointing to long-term supply scarcity and institutional inflows, while bears highlight potential bearish chart patterns and the risk of a broader market reversal.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a massive surge in investor interest and trading volume as the market re-rates the company within the high-growth AI optics and data center infrastructure sector. Community discourse is heavily focused on potential partnerships, the 'semiconductorization' of photonics, and a perceived short squeeze, leading many to actively debate whether the current momentum represents a long-term fundamental shift or an overextended speculative trade.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as investors re-rate the stock as a key AI infrastructure and data center connectivity play following a significant earnings beat and bullish guidance. While community sentiment is divided between those betting on long-term momentum and skeptics who view the stock as overbought and vulnerable to a correction, many are actively tracking its role as a strategic partner to major tech players.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

Semiconductor stocks are trending as the SOXX ETF achieves a historic 18-day winning streak, fueling intense community debate between bulls betting on unstoppable AI-driven liquidity and bears highlighting extreme overvaluation and parabolic RSI signals. While some traders are aggressively adding to leveraged short positions in anticipation of a major reversal, others argue that institutional demand and massive data center investment will continue to sustain the current momentum.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin (XCN) is facing significant community polarization as investors weigh the upcoming Goliath mainnet launch against concerns over price volatility and lack of confirmed commercial partnerships. While some remain committed to long-term accumulation, others express frustration with the token's persistent drawdowns and the aggressive marketing tactics surrounding the project.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending as investors speculate on potential contract announcements following the company's recent expansion into AI-focused semiconductor manufacturing technologies and GaN power applications. Community discussions are heavily divided between long-term supporters highlighting the long-awaited valuation of their Mears Silicon Technology (MST) and vocal skeptics who cite a history of delayed results and lack of commercial revenue.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as investors debate the potential for a long-term supply burn and price recovery, with community members closely tracking exchange burn activity and ecosystem developments. While some traders are aggressively accumulating, others remain cautious, highlighting the high-risk sentiment surrounding the project's historical volatility.

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Compass Therapeutics Inc

Compass Therapeutics is seeing significant investor attention ahead of a pivotal clinical data readout for its Phase 2/3 trial of tovecimig in biliary tract cancer. The community is focused on the potential for strong secondary endpoint results, with many traders closely monitoring the setup as a high-volatility binary event.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is drawing significant investor attention following a $698.6 million IRS tax refund that has bolstered the company's liquidity to approximately $1.5 billion. The community is actively debating the stock's potential for a turnaround given its cleaner post-restructuring balance sheet, while simultaneously tracking high short interest and speculative interest in its silicon carbide technology for AI data center infrastructure.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares is seeing intense investor activity driven by a historic, multi-week winning streak fueled by AI-driven chip demand and optimistic earnings momentum in the sector. While retail investors remain heavily divided between those betting on an unstoppable AI super-cycle and those warning of an overextended bubble, community discussions are currently fixated on whether the recent parabolic price surge is sustainable or nearing a sharp correction.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting Anixa Biosciences Announces Presentation of its...

Anixa Biosciences Highlights Lean Cash Burn, CAR-T Survival Signals, and Phase II Vaccine Plan at Conference

Anixa Biosciences (NASDAQ:ANIX) CEO Dr. Amit Kumar outlined the company's strategy for advancing two clinical-stage oncology programs while maintaining what he described as a "very modest" cash burn during a Water Tower Research conference session moderated by Robert Sassoon, Managing Director of He...

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026

Anixa Biosciences to Participate in RedChip's Biotech Resurgence: Platforms and Pipelines of Today's Innovators Conference on April 16, 2026 Anixa Biosciences to Participate in RedChip's Biotech...

Anixa Biosciences' (ANIX) "Buy" Rating Reiterated at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $10.00 price target on shares of Anixa Biosciences in a research report on Wednesday...

Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026

Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 Anixa Biosciences to Participate in Water Tower Research Insights Conference on April 14, 2026 PR...

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs

Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting Advances in Cancer Immunotherapy Programs Anixa Biosciences CEO Featured on Smart Money Circle Interview Highlighting...

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen

Wall Street Zen lowered Anixa Biosciences from a "hold" rating to a "sell" rating in a research report on Saturday...

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing

Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase...

Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at D. Boral Capital

D. Boral Capital reissued a "buy" rating and set a $10.00 target price on shares of Anixa Biosciences in a report on Tuesday...

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer

Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer Anixa Biosciences Announces...

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The Other segment refers to its legacy operations, including patent licensing. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.08	--	--	N/A
Q1 '26	-$0.09	--	--	N/A
Q4 '25	-$0.09	--	--	N/A
Q3 '25	-$0.08	-$0.07	8.70%	BEAT
Q2 '25	-$0.09	--	--	N/A

ANIX
Anixa Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest ANIX News

ANIXAnixa Biosciences Inc